Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
Let's see if I got this right.
1. Americans fund an Israeli company/lab.
2. A portion of the research is performed by an American team headed by Nick Restifo (good Italian-american boy). Who writes a letter pointing this out.
Israel takes credit.
Why don't these Americans fund American companies/labs that employ Americans?
Sheba Medical Center, Tel Hashomer,
How very interesting.
The hospital's research funding comes from Tel Aviv university and Bar Ilan University - let's start with TAU.
Where do they get their funding?
Tel Aviv University gets 10m grant to start film school The Times of Israel
Producer, New York Giants co-owner, and philanthropic scion Steve Tisch has donated $10 million to Tel Aviv University
General Fund - American Friends of Tel Aviv University
The American friends of TAU
HELP FULFILL TAU'S MISSION
Your generosity may be used for academic development, supporting the first-class research and teaching that are the very heart of the university. It may help create exciting new interdisciplinary study programs, or to nurture the young researchers who will lead TAU into the future.
The other one?
Giving Opportunities - American Friends of Bar-Ilan University
Support Israel's Future...
Give to the Fastest Growing University in Israel
The American Friends of Bar-Ilan provides opportunities to become partners in programs that advance the lives of 33,000 students in the Bar-Ilan academic community, the people of Israel, Jews around the world, and millions of individuals in the society at large who benefit from the University's scientific and medical breakthroughs.
In other words - traitors to America are diverting funds they should be using to fund American research, diverting them to Israel.
Nice of Roudy to highlight how American traitors are sending funds to Israel so Israel can make money from the research they produce from American money.
These traitors should be kicked out of the US of A, all their money confiscated and sent to American universities.
Let's see if I got this right.
1. Americans fund an Israeli company/lab.
2. A portion of the research is performed by an American team headed by Nick Restifo (good Italian-american boy). Who writes a letter pointing this out.
Israel takes credit.
Why don't these Americans fund American companies/labs that employ Americans?
Jews are very influential in the music business in the U.S.
You have to wonder how many more inventions Zionist Israel has just taken the credit for, rather than actually doing the work to "invent" them?
I found this article
WATCH Israel Develops Cure for Melanoma Cancer United with Israel
so this is all about the
Are the supporters of BDS going to boycott this development from Israel?
I was appalled at the comments under the article. While all medical advances are great no matter who is involved in their invention, as its takes a team and years, its one thing to dismiss the real people involved and take credit solely on oneself.
Nicholas P. Restifo, M.D.
Senior Investigator
Surgery Branch
Dr. Restifo pioneered the use of molecularly defined T cell-based immunotherapies by developing mouse models with predictive value for human clinical trials. The Restifo group was amongst the first to identify myeloid-derived cell subsets that impair anti-tumor T cell responses. His work on immunoablation underlies many of the current generation of cellular therapies in the clinic. Dr. Restifo’s group was the first to discover a novel subset of long-lived human T memory stem cells in humans. These fundamental discoveries are aimed at improving the treatment of adults and children with metastatic cancer.
Areas of Expertise
1) immunotherapy 2) immunoablation 3) adoptive cell therapy 4) novel mouse tumor models 5) T cell development 6) T memory stem cells
Now adoptive cell therapy was helped along by an Dr. Rosenburg (etc) but it was done in the US , not Israel.
No one and no country develops or invents anything in solo, they work on knowledge handed down to them from years of intelligent people and work as a team among countries.
Its very dishonest and arrogant to make such false claims as Israel has done and they should retract it.
Jews are very influential in the music business in the U.S.
Jews are very influential in the music business in the U.S.
If this was in response to my post about Bon Jovi, he was looking forward to playing in Israel, but threats from BDS made him cancel his first concert there. Now he made it part of his European tour. Are you saying that he's playing there against his will? I highly doubt that. If you have any respect for Bon Jovi, you wouldn't suspect him of false statements in his press releases. He could easily not play there, thanks to BDS. It's the opposite of what you think. Not every Roman Catholic shares your opinion about Israel.
Too bad all these people donate to Israel instead of..Indonesia for instance..is such a waste!
These American traitors are funding Israeli instead of American research.
I see you can't manage a comment on that.
Care to try?
I found this article
WATCH Israel Develops Cure for Melanoma Cancer United with Israel
so this is all about the
Are the supporters of BDS going to boycott this development from Israel?
I was appalled at the comments under the article. While all medical advances are great no matter who is involved in their invention, as its takes a team and years, its one thing to dismiss the real people involved and take credit solely on oneself.
Nicholas P. Restifo, M.D.
Senior Investigator
Surgery Branch
Dr. Restifo pioneered the use of molecularly defined T cell-based immunotherapies by developing mouse models with predictive value for human clinical trials. The Restifo group was amongst the first to identify myeloid-derived cell subsets that impair anti-tumor T cell responses. His work on immunoablation underlies many of the current generation of cellular therapies in the clinic. Dr. Restifo’s group was the first to discover a novel subset of long-lived human T memory stem cells in humans. These fundamental discoveries are aimed at improving the treatment of adults and children with metastatic cancer.
Areas of Expertise
1) immunotherapy 2) immunoablation 3) adoptive cell therapy 4) novel mouse tumor models 5) T cell development 6) T memory stem cells
Now adoptive cell therapy was helped along by an Dr. Rosenburg (etc) but it was done in the US , not Israel.
No one and no country develops or invents anything in solo, they work on knowledge handed down to them from years of intelligent people and work as a team among countries.
Its very dishonest and arrogant to make such false claims as Israel has done and they should retract it.
Not necessarily. In this case it was developed by Israel and Isrseli doctors. While Muslim savages are busy creating new ways to hate and kill people, Israelis are busy healing the world.
Sheba doctors: Experimental treatment successful in half of melanoma cases
Israeli researchers have found that an experimental skin cancer treatment can reduce some tumors and cause others or disappear entirely, doctors at Sheba Medical Center, Tel Hashomer, wrote in a recent article in the scientific journal Clinical Cancer Research.
The treatment has been tried on melanoma patients who have been told they have only a few months to live because other treatments have failed. It uses the cells from the patients' own immune systems to attack the cancer.
In nearly half the cases in the experiment, the treatment caused the tumor to shrink or disappear entirely. Twenty-nine patients received the treatment over the past two and a half years. Doctors at Sheba's Ella Institute for Treatment and Research of Melanoma and Skin Cancer reported their findings in the May issue of Clinical Cancer Research.
"Melanoma is considered one of the most difficult cancers," said Prof. Jacob Schachter, head of the Ella Institute and deputy director of oncology at Sheba. "At its late stages it metastasizes to many other parts of the body, unlike, for example, cancer of the large intestine, which metastasizes mainly to the liver. In addition, about half of metastatic melanoma patients are young, and their life expectancy is six to eight months on average."
Sheba is the second medical center in the world to implement the treatment, which was developed over the past decade by the National Cancer Institute in Maryland.
The treatment, approved by the Health Ministry and Sheba's committee on human experimentation, was offered only to patients whose cancer had spread and for whom other treatments, including surgery and chemotherapy, had failed.
The treatment involves taking cells from the patients' immune system, known as tumor infiltrating lymphocytes. These cells, which kill cancer cells and are found in cancerous organs, are developed in a laboratory and then returned to the patient's body to attack the cancer.
At the first stage of the treatment, a cancerous organ relatively easy to remove by surgery is removed, and its lymphocytes are isolated. They are then grown for three to four weeks in the laboratory in bags with 40 liters of fluid until there are 1,000 times more than the initial number. A week before the end of the cell-generating process, the patients are given aggressive chemotherapy to suppress their natural immune system, so that the body will easily accept the laboratory-grown cells.
About a week after the chemotherapy, with the patient still hospitalized, the patient is given one infusion of a concentrated dose of the laboratory-generated cells. The patient is also given interleukin-2, which restarts the immune system.
"The cells that are inserted into the body already know the metastases of the cancer, because they came from one of them. They therefore head, like guided missiles, toward the metastases and take it apart," Schachter said.
After the cells of the metastases are destroyed, white blood cells called microphages take apart their remnants and turn them into refuse. The immune system recovers within two to three weeks, when the patient goes home. A month later the patient undergoes a CAT scan to see how the treatment has affected the cancer.
The Sheba team reported that 48 percent of the patients responded to the treatment. Out of 29 patients, three experienced the complete disappearence of the tumor and the metastases a month after treatment. In 11 other cases the response was partial, but the patients are still alive and are now functioning again. The first patient whose metastases disappeared is still alive after more than two years, and the other two are still alive after 16 months and 10 months. Among the patients whose tumors partially shrank, four have been alive for 18, 24, 27 and 16 months, respectively, and report improved quality of life. All patients undergo CAT scans every three months.
In addition to Schachter, the team reporting the findings includes Dr. Michal Besser, head of the Ella Institute laboratory, and Dr. Avi Treves, Ella's scientific director and deputy head of the Sheba Cancer Research Center. The encouraging clinical findings and the eventual simplification of the treatment will have a significant impact on this generation of cellular treatments for cancer, the researchers wrote.
According to cancer statistics collected by the Health Ministry, 1,300 new melanoma cases were diagnosed in 2008, 100 new cases more than in the previous year. Of these, 830 were of the invasive type of melanoma.
Sheba is expected to submit a request to the Health Ministry soon to recognize the treatment as non-experimental in patients with terminal cancer.
The current findings are based on the second generation of experimental treatment, which makes use of cells that have undergone short-term generation in the laboratory and are injected into the patient's body while the cells are still young.
"The less time the cells grow in a laboratory culture, the more aggressive they are in acting against the metastases after being reintroduced to the body," Schachter said.
Sheba is also working on expanding the technology to other types of cancer, including terminal kidney cancer. "Specific methods must be developed for each cancer to grow the immune system's components," Treves said.
Sheba Medical Center, Tel Hashomer,
How very interesting.
The hospital's research funding comes from Tel Aviv university and Bar Ilan University - let's start with TAU.
Where do they get their funding?
Tel Aviv University gets 10m grant to start film school The Times of Israel
Producer, New York Giants co-owner, and philanthropic scion Steve Tisch has donated $10 million to Tel Aviv University
General Fund - American Friends of Tel Aviv University
The American friends of TAU
HELP FULFILL TAU'S MISSION
Your generosity may be used for academic development, supporting the first-class research and teaching that are the very heart of the university. It may help create exciting new interdisciplinary study programs, or to nurture the young researchers who will lead TAU into the future.
The other one?
Giving Opportunities - American Friends of Bar-Ilan University
Support Israel's Future...
Give to the Fastest Growing University in Israel
The American Friends of Bar-Ilan provides opportunities to become partners in programs that advance the lives of 33,000 students in the Bar-Ilan academic community, the people of Israel, Jews around the world, and millions of individuals in the society at large who benefit from the University's scientific and medical breakthroughs.
In other words - traitors to America are diverting funds they should be using to fund American research, diverting them to Israel.
Nice of Roudy to highlight how American traitors are sending funds to Israel so Israel can make money from the research they produce from American money.
These traitors should be kicked out of the US of A, all their money confiscated and sent to American universities.
And Oprah Winfrey started a school for girls in South Africa, so what?
In the case of Bar-Ilan you just provided a link asking for donations--no actual statistics.
Anyway, are you saying that the oil-rich Arab nations don't contribute to mankind due to a lack of funds? Saudi Arabia and Kuwait don't charge citizens of their countries income taxes, because of their wealth.
As for Iran, I can't understand them at all. I don't have the know-how or capabilities to build a nuclear bomb. I guess they have people who do. If they have scientists who are capable of building nuclear bombs, why don't they get them to do something constructive for mankind instead, like getting them to research cures for diseases? And that goes for you too, Indofred. Instead of spending your all waking hours hating and being jealous of Israel, why don't you do something constructive for mankind?
Iran is very advanced in medicine. Yes Iran has very intelligent people unlike Israel who needed the French to help them with their nukes.
SA couldn't figure out where Mers came from for a long time, they do not really do anything much.
And Oprah Winfrey started a school for girls in South Africa, so what?
Has south Africa ever attacked and killed Americans?
Let's see if I got this right.
1. Americans fund an Israeli company/lab.
2. A portion of the research is performed by an American team headed by Nick Restifo (good Italian-american boy). Who writes a letter pointing this out.
Israel takes credit.
Why don't these Americans fund American companies/labs that employ Americans?
which was developed over the past decade by the National Cancer Institute in Maryland.
that is where one should donate money , also I do not think Sheba is the
I found this article
WATCH Israel Develops Cure for Melanoma Cancer United with Israel
so this is all about the
Are the supporters of BDS going to boycott this development from Israel?
I was appalled at the comments under the article. While all medical advances are great no matter who is involved in their invention, as its takes a team and years, its one thing to dismiss the real people involved and take credit solely on oneself.
Nicholas P. Restifo, M.D.
Senior Investigator
Surgery Branch
Dr. Restifo pioneered the use of molecularly defined T cell-based immunotherapies by developing mouse models with predictive value for human clinical trials. The Restifo group was amongst the first to identify myeloid-derived cell subsets that impair anti-tumor T cell responses. His work on immunoablation underlies many of the current generation of cellular therapies in the clinic. Dr. Restifo’s group was the first to discover a novel subset of long-lived human T memory stem cells in humans. These fundamental discoveries are aimed at improving the treatment of adults and children with metastatic cancer.
Areas of Expertise
1) immunotherapy 2) immunoablation 3) adoptive cell therapy 4) novel mouse tumor models 5) T cell development 6) T memory stem cells
Now adoptive cell therapy was helped along by an Dr. Rosenburg (etc) but it was done in the US , not Israel.
No one and no country develops or invents anything in solo, they work on knowledge handed down to them from years of intelligent people and work as a team among countries.
Its very dishonest and arrogant to make such false claims as Israel has done and they should retract it.
Not necessarily. In this case it was developed by Israel and Isrseli doctors. While Muslim savages are busy creating new ways to hate and kill people, Israelis are busy healing the world.
Sheba doctors: Experimental treatment successful in half of melanoma cases
Israeli researchers have found that an experimental skin cancer treatment can reduce some tumors and cause others or disappear entirely, doctors at Sheba Medical Center, Tel Hashomer, wrote in a recent article in the scientific journal Clinical Cancer Research.
The treatment has been tried on melanoma patients who have been told they have only a few months to live because other treatments have failed. It uses the cells from the patients' own immune systems to attack the cancer.
In nearly half the cases in the experiment, the treatment caused the tumor to shrink or disappear entirely. Twenty-nine patients received the treatment over the past two and a half years. Doctors at Sheba's Ella Institute for Treatment and Research of Melanoma and Skin Cancer reported their findings in the May issue of Clinical Cancer Research.
"Melanoma is considered one of the most difficult cancers," said Prof. Jacob Schachter, head of the Ella Institute and deputy director of oncology at Sheba. "At its late stages it metastasizes to many other parts of the body, unlike, for example, cancer of the large intestine, which metastasizes mainly to the liver. In addition, about half of metastatic melanoma patients are young, and their life expectancy is six to eight months on average."
Sheba is the second medical center in the world to implement the treatment, which was developed over the past decade by the National Cancer Institute in Maryland.
The treatment, approved by the Health Ministry and Sheba's committee on human experimentation, was offered only to patients whose cancer had spread and for whom other treatments, including surgery and chemotherapy, had failed.
The treatment involves taking cells from the patients' immune system, known as tumor infiltrating lymphocytes. These cells, which kill cancer cells and are found in cancerous organs, are developed in a laboratory and then returned to the patient's body to attack the cancer.
At the first stage of the treatment, a cancerous organ relatively easy to remove by surgery is removed, and its lymphocytes are isolated. They are then grown for three to four weeks in the laboratory in bags with 40 liters of fluid until there are 1,000 times more than the initial number. A week before the end of the cell-generating process, the patients are given aggressive chemotherapy to suppress their natural immune system, so that the body will easily accept the laboratory-grown cells.
About a week after the chemotherapy, with the patient still hospitalized, the patient is given one infusion of a concentrated dose of the laboratory-generated cells. The patient is also given interleukin-2, which restarts the immune system.
"The cells that are inserted into the body already know the metastases of the cancer, because they came from one of them. They therefore head, like guided missiles, toward the metastases and take it apart," Schachter said.
After the cells of the metastases are destroyed, white blood cells called microphages take apart their remnants and turn them into refuse. The immune system recovers within two to three weeks, when the patient goes home. A month later the patient undergoes a CAT scan to see how the treatment has affected the cancer.
The Sheba team reported that 48 percent of the patients responded to the treatment. Out of 29 patients, three experienced the complete disappearence of the tumor and the metastases a month after treatment. In 11 other cases the response was partial, but the patients are still alive and are now functioning again. The first patient whose metastases disappeared is still alive after more than two years, and the other two are still alive after 16 months and 10 months. Among the patients whose tumors partially shrank, four have been alive for 18, 24, 27 and 16 months, respectively, and report improved quality of life. All patients undergo CAT scans every three months.
In addition to Schachter, the team reporting the findings includes Dr. Michal Besser, head of the Ella Institute laboratory, and Dr. Avi Treves, Ella's scientific director and deputy head of the Sheba Cancer Research Center. The encouraging clinical findings and the eventual simplification of the treatment will have a significant impact on this generation of cellular treatments for cancer, the researchers wrote.
According to cancer statistics collected by the Health Ministry, 1,300 new melanoma cases were diagnosed in 2008, 100 new cases more than in the previous year. Of these, 830 were of the invasive type of melanoma.
Sheba is expected to submit a request to the Health Ministry soon to recognize the treatment as non-experimental in patients with terminal cancer.
The current findings are based on the second generation of experimental treatment, which makes use of cells that have undergone short-term generation in the laboratory and are injected into the patient's body while the cells are still young.
"The less time the cells grow in a laboratory culture, the more aggressive they are in acting against the metastases after being reintroduced to the body," Schachter said.
Sheba is also working on expanding the technology to other types of cancer, including terminal kidney cancer. "Specific methods must be developed for each cancer to grow the immune system's components," Treves said.
So it was a false Headline, they incorporated the treatment discovered at the Cancer Research Center in the US, that is where the donations need to be sent.
You have to wonder how many more inventions Zionist Israel has just taken the credit for, rather than actually doing the work to "invent" them?
Jews are very influential in the music business in the U.S.
If this was in response to my post about Bon Jovi, he was looking forward to playing in Israel, but threats from BDS made him cancel his first concert there. Now he made it part of his European tour. Are you saying that he's playing there against his will? I highly doubt that. If you have any respect for Bon Jovi, you wouldn't suspect him of false statements in his press releases. He could easily not play there, thanks to BDS. It's the opposite of what you think. Not every Roman Catholic shares your opinion about Israel.
Some famous performers played in Sun City, e.g. Elton John, during Apartheid, it didn't make it right.
Sheba Medical Center, Tel Hashomer,
How very interesting.
The hospital's research funding comes from Tel Aviv university and Bar Ilan University - let's start with TAU.
Where do they get their funding?
Tel Aviv University gets 10m grant to start film school The Times of Israel
Producer, New York Giants co-owner, and philanthropic scion Steve Tisch has donated $10 million to Tel Aviv University
General Fund - American Friends of Tel Aviv University
The American friends of TAU
HELP FULFILL TAU'S MISSION
Your generosity may be used for academic development, supporting the first-class research and teaching that are the very heart of the university. It may help create exciting new interdisciplinary study programs, or to nurture the young researchers who will lead TAU into the future.
The other one?
Giving Opportunities - American Friends of Bar-Ilan University
Support Israel's Future...
Give to the Fastest Growing University in Israel
The American Friends of Bar-Ilan provides opportunities to become partners in programs that advance the lives of 33,000 students in the Bar-Ilan academic community, the people of Israel, Jews around the world, and millions of individuals in the society at large who benefit from the University's scientific and medical breakthroughs.
In other words - traitors to America are diverting funds they should be using to fund American research, diverting them to Israel.
Nice of Roudy to highlight how American traitors are sending funds to Israel so Israel can make money from the research they produce from American money.
These traitors should be kicked out of the US of A, all their money confiscated and sent to American universities.
And Oprah Winfrey started a school for girls in South Africa, so what?
In the case of Bar-Ilan you just provided a link asking for donations--no actual statistics.
Anyway, are you saying that the oil-rich Arab nations don't contribute to mankind due to a lack of funds? Saudi Arabia and Kuwait don't charge citizens of their countries income taxes, because of their wealth.
As for Iran, I can't understand them at all. I don't have the know-how or capabilities to build a nuclear bomb. I guess they have people who do. If they have scientists who are capable of building nuclear bombs, why don't they get them to do something constructive for mankind instead, like getting them to research cures for diseases? And that goes for you too, Indofred. Instead of spending your all waking hours hating and being jealous of Israel, why don't you do something constructive for mankind?
Iran is very advanced in medicine. Yes Iran has very intelligent people unlike Israel who needed the French to help them with their nukes.
SA couldn't figure out where Mers came from for a long time, they do not really do anything much.
And your evidence from a non Iranian source as to their advances in medicine is what ?
I found this article
WATCH Israel Develops Cure for Melanoma Cancer United with Israel
so this is all about the
Are the supporters of BDS going to boycott this development from Israel?
I was appalled at the comments under the article. While all medical advances are great no matter who is involved in their invention, as its takes a team and years, its one thing to dismiss the real people involved and take credit solely on oneself.
Nicholas P. Restifo, M.D.
Senior Investigator
Surgery Branch
Dr. Restifo pioneered the use of molecularly defined T cell-based immunotherapies by developing mouse models with predictive value for human clinical trials. The Restifo group was amongst the first to identify myeloid-derived cell subsets that impair anti-tumor T cell responses. His work on immunoablation underlies many of the current generation of cellular therapies in the clinic. Dr. Restifo’s group was the first to discover a novel subset of long-lived human T memory stem cells in humans. These fundamental discoveries are aimed at improving the treatment of adults and children with metastatic cancer.
Areas of Expertise
1) immunotherapy 2) immunoablation 3) adoptive cell therapy 4) novel mouse tumor models 5) T cell development 6) T memory stem cells
Now adoptive cell therapy was helped along by an Dr. Rosenburg (etc) but it was done in the US , not Israel.
No one and no country develops or invents anything in solo, they work on knowledge handed down to them from years of intelligent people and work as a team among countries.
Its very dishonest and arrogant to make such false claims as Israel has done and they should retract it.
Not necessarily. In this case it was developed by Israel and Isrseli doctors. While Muslim savages are busy creating new ways to hate and kill people, Israelis are busy healing the world.
Sheba doctors: Experimental treatment successful in half of melanoma cases
Israeli researchers have found that an experimental skin cancer treatment can reduce some tumors and cause others or disappear entirely, doctors at Sheba Medical Center, Tel Hashomer, wrote in a recent article in the scientific journal Clinical Cancer Research.
The treatment has been tried on melanoma patients who have been told they have only a few months to live because other treatments have failed. It uses the cells from the patients' own immune systems to attack the cancer.
In nearly half the cases in the experiment, the treatment caused the tumor to shrink or disappear entirely. Twenty-nine patients received the treatment over the past two and a half years. Doctors at Sheba's Ella Institute for Treatment and Research of Melanoma and Skin Cancer reported their findings in the May issue of Clinical Cancer Research.
"Melanoma is considered one of the most difficult cancers," said Prof. Jacob Schachter, head of the Ella Institute and deputy director of oncology at Sheba. "At its late stages it metastasizes to many other parts of the body, unlike, for example, cancer of the large intestine, which metastasizes mainly to the liver. In addition, about half of metastatic melanoma patients are young, and their life expectancy is six to eight months on average."
Sheba is the second medical center in the world to implement the treatment, which was developed over the past decade by the National Cancer Institute in Maryland.
The treatment, approved by the Health Ministry and Sheba's committee on human experimentation, was offered only to patients whose cancer had spread and for whom other treatments, including surgery and chemotherapy, had failed.
The treatment involves taking cells from the patients' immune system, known as tumor infiltrating lymphocytes. These cells, which kill cancer cells and are found in cancerous organs, are developed in a laboratory and then returned to the patient's body to attack the cancer.
At the first stage of the treatment, a cancerous organ relatively easy to remove by surgery is removed, and its lymphocytes are isolated. They are then grown for three to four weeks in the laboratory in bags with 40 liters of fluid until there are 1,000 times more than the initial number. A week before the end of the cell-generating process, the patients are given aggressive chemotherapy to suppress their natural immune system, so that the body will easily accept the laboratory-grown cells.
About a week after the chemotherapy, with the patient still hospitalized, the patient is given one infusion of a concentrated dose of the laboratory-generated cells. The patient is also given interleukin-2, which restarts the immune system.
"The cells that are inserted into the body already know the metastases of the cancer, because they came from one of them. They therefore head, like guided missiles, toward the metastases and take it apart," Schachter said.
After the cells of the metastases are destroyed, white blood cells called microphages take apart their remnants and turn them into refuse. The immune system recovers within two to three weeks, when the patient goes home. A month later the patient undergoes a CAT scan to see how the treatment has affected the cancer.
The Sheba team reported that 48 percent of the patients responded to the treatment. Out of 29 patients, three experienced the complete disappearence of the tumor and the metastases a month after treatment. In 11 other cases the response was partial, but the patients are still alive and are now functioning again. The first patient whose metastases disappeared is still alive after more than two years, and the other two are still alive after 16 months and 10 months. Among the patients whose tumors partially shrank, four have been alive for 18, 24, 27 and 16 months, respectively, and report improved quality of life. All patients undergo CAT scans every three months.
In addition to Schachter, the team reporting the findings includes Dr. Michal Besser, head of the Ella Institute laboratory, and Dr. Avi Treves, Ella's scientific director and deputy head of the Sheba Cancer Research Center. The encouraging clinical findings and the eventual simplification of the treatment will have a significant impact on this generation of cellular treatments for cancer, the researchers wrote.
According to cancer statistics collected by the Health Ministry, 1,300 new melanoma cases were diagnosed in 2008, 100 new cases more than in the previous year. Of these, 830 were of the invasive type of melanoma.
Sheba is expected to submit a request to the Health Ministry soon to recognize the treatment as non-experimental in patients with terminal cancer.
The current findings are based on the second generation of experimental treatment, which makes use of cells that have undergone short-term generation in the laboratory and are injected into the patient's body while the cells are still young.
"The less time the cells grow in a laboratory culture, the more aggressive they are in acting against the metastases after being reintroduced to the body," Schachter said.
Sheba is also working on expanding the technology to other types of cancer, including terminal kidney cancer. "Specific methods must be developed for each cancer to grow the immune system's components," Treves said.
So it was a false Headline, they incorporated the treatment discovered at the Cancer Research Center in the US, that is where the donations need to be sent.
